Cargando…

Endoscopic mucosal resection with double band ligation versus endoscopic submucosal dissection for small rectal neuroendocrine tumors

BACKGROUND: Endoscopic resection remains an effective method for the treatment of small rectal neuroendocrine tumors (NETs) (≤ 10 mm). Moreover, endoscopic mucosal resection (EMR) with double band ligation (EMR-dB), a simplified modification of EMR with band ligation, is an alternative strategy to r...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Jia-Lan, Gan, Ri-Yun, Chen, Ze-Han, Gao, Ruo-Yu, Li, De-Feng, Wang, Li-Sheng, Yao, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080593/
https://www.ncbi.nlm.nih.gov/pubmed/37032804
http://dx.doi.org/10.4240/wjgs.v15.i3.440
_version_ 1785020956422438912
author Huang, Jia-Lan
Gan, Ri-Yun
Chen, Ze-Han
Gao, Ruo-Yu
Li, De-Feng
Wang, Li-Sheng
Yao, Jun
author_facet Huang, Jia-Lan
Gan, Ri-Yun
Chen, Ze-Han
Gao, Ruo-Yu
Li, De-Feng
Wang, Li-Sheng
Yao, Jun
author_sort Huang, Jia-Lan
collection PubMed
description BACKGROUND: Endoscopic resection remains an effective method for the treatment of small rectal neuroendocrine tumors (NETs) (≤ 10 mm). Moreover, endoscopic mucosal resection (EMR) with double band ligation (EMR-dB), a simplified modification of EMR with band ligation, is an alternative strategy to remove small rectal NETs. AIM: To evaluate the feasibility and safety of EMR-dB for the treatment of small rectal NETs (≤ 10 mm). METHODS: A total of 50 patients with small rectal NETs, without regional lymph node enlargement or distant metastasis confirmed by endoscopic ultrasound, computerized tomography scan, or magnetic resonance imaging, were enrolled in the study from March 2021 to June 2022. These patients were randomly assigned into the EMR-dB (n = 25) group or endoscopic submucosal dissection (ESD) group (n = 25). The characteristics of the patients and tumors, procedure time, devices cost, complete resection rate, complications, and recurrence outcomes were analyzed. RESULTS: There were 25 patients (13 males, 12 females; age range 28-68 years old) in the EMR-dB group, and the ESD group contained 25 patients (15 males, 10 females; age range 25-70 years old). Both groups had similar lesion sizes (EMR-dB 4.53 ± 1.02 mm, ESD 5.140 ± 1.74 mm; P = 0.141) and resected lesion sizes(1.32 ± 0.52 cm vs 1.58 ± 0.84 cm; P = 0.269). Furthermore, the histological complete resection and en bloc resection rates were achieved in all patients (100% for each). In addition, there was no significant difference in the complication rate between the two groups. However, the procedure time was significantly shorter and the devices cost was significantly lower in the EMR-dB group. Besides, there was no recurrence in both groups during the follow-up period. CONCLUSION: The procedure time of EMR-dB was shorter compared with ESD, and both approaches showed a similar curative effect. Taken together, EMR-dB was a feasible and safe option for the treatment of small rectal NETs.
format Online
Article
Text
id pubmed-10080593
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-100805932023-04-08 Endoscopic mucosal resection with double band ligation versus endoscopic submucosal dissection for small rectal neuroendocrine tumors Huang, Jia-Lan Gan, Ri-Yun Chen, Ze-Han Gao, Ruo-Yu Li, De-Feng Wang, Li-Sheng Yao, Jun World J Gastrointest Surg Randomized Controlled Trial BACKGROUND: Endoscopic resection remains an effective method for the treatment of small rectal neuroendocrine tumors (NETs) (≤ 10 mm). Moreover, endoscopic mucosal resection (EMR) with double band ligation (EMR-dB), a simplified modification of EMR with band ligation, is an alternative strategy to remove small rectal NETs. AIM: To evaluate the feasibility and safety of EMR-dB for the treatment of small rectal NETs (≤ 10 mm). METHODS: A total of 50 patients with small rectal NETs, without regional lymph node enlargement or distant metastasis confirmed by endoscopic ultrasound, computerized tomography scan, or magnetic resonance imaging, were enrolled in the study from March 2021 to June 2022. These patients were randomly assigned into the EMR-dB (n = 25) group or endoscopic submucosal dissection (ESD) group (n = 25). The characteristics of the patients and tumors, procedure time, devices cost, complete resection rate, complications, and recurrence outcomes were analyzed. RESULTS: There were 25 patients (13 males, 12 females; age range 28-68 years old) in the EMR-dB group, and the ESD group contained 25 patients (15 males, 10 females; age range 25-70 years old). Both groups had similar lesion sizes (EMR-dB 4.53 ± 1.02 mm, ESD 5.140 ± 1.74 mm; P = 0.141) and resected lesion sizes(1.32 ± 0.52 cm vs 1.58 ± 0.84 cm; P = 0.269). Furthermore, the histological complete resection and en bloc resection rates were achieved in all patients (100% for each). In addition, there was no significant difference in the complication rate between the two groups. However, the procedure time was significantly shorter and the devices cost was significantly lower in the EMR-dB group. Besides, there was no recurrence in both groups during the follow-up period. CONCLUSION: The procedure time of EMR-dB was shorter compared with ESD, and both approaches showed a similar curative effect. Taken together, EMR-dB was a feasible and safe option for the treatment of small rectal NETs. Baishideng Publishing Group Inc 2023-03-27 2023-03-27 /pmc/articles/PMC10080593/ /pubmed/37032804 http://dx.doi.org/10.4240/wjgs.v15.i3.440 Text en ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
spellingShingle Randomized Controlled Trial
Huang, Jia-Lan
Gan, Ri-Yun
Chen, Ze-Han
Gao, Ruo-Yu
Li, De-Feng
Wang, Li-Sheng
Yao, Jun
Endoscopic mucosal resection with double band ligation versus endoscopic submucosal dissection for small rectal neuroendocrine tumors
title Endoscopic mucosal resection with double band ligation versus endoscopic submucosal dissection for small rectal neuroendocrine tumors
title_full Endoscopic mucosal resection with double band ligation versus endoscopic submucosal dissection for small rectal neuroendocrine tumors
title_fullStr Endoscopic mucosal resection with double band ligation versus endoscopic submucosal dissection for small rectal neuroendocrine tumors
title_full_unstemmed Endoscopic mucosal resection with double band ligation versus endoscopic submucosal dissection for small rectal neuroendocrine tumors
title_short Endoscopic mucosal resection with double band ligation versus endoscopic submucosal dissection for small rectal neuroendocrine tumors
title_sort endoscopic mucosal resection with double band ligation versus endoscopic submucosal dissection for small rectal neuroendocrine tumors
topic Randomized Controlled Trial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080593/
https://www.ncbi.nlm.nih.gov/pubmed/37032804
http://dx.doi.org/10.4240/wjgs.v15.i3.440
work_keys_str_mv AT huangjialan endoscopicmucosalresectionwithdoublebandligationversusendoscopicsubmucosaldissectionforsmallrectalneuroendocrinetumors
AT ganriyun endoscopicmucosalresectionwithdoublebandligationversusendoscopicsubmucosaldissectionforsmallrectalneuroendocrinetumors
AT chenzehan endoscopicmucosalresectionwithdoublebandligationversusendoscopicsubmucosaldissectionforsmallrectalneuroendocrinetumors
AT gaoruoyu endoscopicmucosalresectionwithdoublebandligationversusendoscopicsubmucosaldissectionforsmallrectalneuroendocrinetumors
AT lidefeng endoscopicmucosalresectionwithdoublebandligationversusendoscopicsubmucosaldissectionforsmallrectalneuroendocrinetumors
AT wanglisheng endoscopicmucosalresectionwithdoublebandligationversusendoscopicsubmucosaldissectionforsmallrectalneuroendocrinetumors
AT yaojun endoscopicmucosalresectionwithdoublebandligationversusendoscopicsubmucosaldissectionforsmallrectalneuroendocrinetumors